CTOs on the Move


 
ACell, Inc. is a leading regenerative medicine company focused on the development, manufacturing, and commercialization of unique proprietary extracellular matrix (ECM) products to facilitate the repair and remodeling of damaged tissues. ACell is committed to becoming and remaining an innovative leader in regenerative medical technology, offering superior healing options for doctors and patients. ACell is a privately held company and operates manufacturing facilities in Columbia, MD and Lafayette, IN.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.acell.com
  • 6640 Eli Whitney Drive
    Columbia, MD USA 21046
  • Phone: 800.826.2926

Executives

Name Title Contact Details

Similar Companies

Contract Pharmacy Services

Contract Pharmacy Services is a Warrington, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Intermountain Therapy Animals

Intermountain Therapy Animals is a Salt Lake City, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

FlexMedical Disposables

FlexMedical Disposables is a Irving, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Goetze Dental

Goetze Dental is a Kansas City, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Integrity Applications

Integrity Applications is dedicated to developing breakthrough innovations in non-invasive glucose monitoring devices. Since its founding in 2001, Integrity Applications has been committed to improving the quality of life for people with diabetes by removing the obstacles of traditional invasive devices, namely painful pricking of fingertips, added costs as a result of disposables, as well as inconvenience. Integrity Applications has developed a state-of-the-art way to measure glucose levels using three non-invasive technologies, ultrasound, thermal, and electromagnetic in combination with a proprietary algorithm to produce a weighted glucose measurement. After proof of concept in 2002, Integrity Applications developed the first working prototype, GlucoTrack in August 2003. GlucoTrack® Model DF-F received CE Mark approval in June 2013 and KFDA in March 2016. GlucoTrack is currently being marketed in the European Union and in South Korea.